[1] Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017[J]. CA Cancer J Clin,2017,67(1):7-30. [2] Chen WQ, Zheng RS, Peter D, et al.Cancer Statistics in China, 2015[J]. CA Cancer J Clin,2016,66:115-132. [3] Yang F, Jin C, Yang D, et al.Magnetic functionalised carbon nanotubes as drug vehicles for cancer lymph node metastasis treatment[J]. Eur J Cancer,2011,47(12):1873-1882. [4] Yu W, Cao X, Xu G, et al.Potential role for carbon nanoparticles to guide central neck dissection in patients with papillary thyroid cancer[J]. Surgery,2016,160(3):755-761. [5] Mazzaferri EL, Massoll N.Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin[J]. Endocr Relat Cancer,2002,9(4):227-247. [6] Simon D, Goretzki PE, Witte J, et al.Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma[J]. World J Surg,1996,20(7):860-866. [7] Conzo G, Avenia N, Bellastella G, et al.The role of surgery in the current management of differentiated thyroid cancer[J]. Endocrine,2014,47(2):380-388. [8] Hay ID, Thompson GB, Grant CS, et al.Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trend in initial therapy and long-term outcome in 2444 consecutively treated patients[J]. World J Med,2002,26(8):879-885. [9] Mazzaferri EL, Jhiang SM.Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer[J]. Am J Med,1994,97(5):418-428. [10] Dionigi G, Bacuzzi A, Bertocchi V, et al.Prospectives and surgical usefulness of perioperative parathyroid hormone assay in thyroid surgery[J]. Expert Rev Med Devices,2008,5(6):699-704. [11] Lim DJ, Baek KH, Lee YS, et al.Clinical, histopatholo-gical, and molecular characteristics of papillary thyroid microcarcinoma[J]. Thyroid,2007,17(9):883-888. [12] Han N, Bumpous JM, Goldstein RE, et al.Intra-operative parathyroid identification using methylene blue in parathyroidsurgery[J]. Am Surg,2007,73(8):820-823. [13] Hao RT, Chen J, Zhao LH, et al.Sentinel lymph node biopsy using carbon nanoparticles for Chinese patients with papillary thyroid microcarcinoma[J]. Eur J Surg Oncol,2012,38(8):718-724. [14] Catarci M, Guadagni S, Zaraca F, et al.Prospective randomized evaluation of preoperative endoscopic vital staining using CH-40 for lymph node dissection in gastric cancer[J]. Ann Surg Oncol,1998,5(7):580-584. [15] Vasala A, Nair HG, Rao ST, et al.Impact of methylene blue staining in the retrieval of lymph nodes in resected colorectal cancer specimens[J]. Indian J Pathol Microbiol,2016,59(4):504-506. [16] Li Y, Jian WH, Guo ZM, et al.A meta-analysis of carbon nanoparticles for identifying lymph nodes and protecting parathyroid glands during surger[J]. Otolaryngol Head Neck Surg,2015,152(6):1007-1016. [17] Bruno R, Giannasio P, Chiarella R, et al.Identification of a neck lump as a lymph node metastasis from an occult contralateral papillary microcarcinoma of the thyroid: key role of thyroglobulin assay in the fine-needle aspirate[J]. Thyroid,2009,19(5):531-533. |